Chuck Hadley, J.D., M.B.A

Chuck has had a thirty-year career in Medical Technology as a Venture capitalist and entrepreneur. He was a partner at Hillman Medical Ventures, Rock Hill Ventures and Cardinal Partners. He led investments in Ultracision (acquired by JNJ), Cytyc (acquired by Hologic), Endius (acquired by Zimmer), Talaria Therapeutics (acquired by Esperion--Pfizer), Proxima Therapeutics (acquired by Hologic) and many others. He currently serves as Executive Chairman of ActiveProtective Technologies and is a member of the board of PASTRx and PhotoSonix.

Chuck is a Phi Beta Kappa graduate of the George Washington University and received his J.D. and M.B.A. degrees from Stanford University in 1983.